Research Partnership welcomes Marie Cawkwell
Research Partnership is pleased to welcome Marie Cawkwell as a Senior Analyst
Marie joins the company’s specialist market access team Access Partnership, which supports the world’s leading pharmaceutical, biotech and device manufacturers in market access, pricing, and reimbursement. She has accumulated over 5 years’ experience in healthcare research and consultancy since graduating from the University of Liverpool with an M.Res in Biomedical Science, and brings with her a wealth of skills and knowledge from her time working for a variety of market access consultancies.
Access Partnership welcomes Kevin Mayo as Executive Vice President
Healthcare market access and consultancy specialist Access Partnership welcomes Kevin Mayo as Executive Vice President to the company’s US office in Philadelphia and Pascal King as Global Director to newly-appointed London Headquarters.
Thalia Nikoglou and Ahmed Edathodu have also joined the company as Consultants.
Mike Mallinson, President, comments, “We are very pleased to welcome these talented individuals to our team at what is a key time for the Access Partnership. Growing demand from clients has meant we have had to scale up very quickly and we will be announcing further appointments in the near future. From our new, large headquarters based at Putney Bridge in London we are able to continue to expand our international operations in line with our strategy and together with our sister company the Research Partnership, we are now a team of over 116 global healthcare executives.”
Visit the Access Partnership website to read the full announcement. »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »
Mike Mallinson joins the Access Partnership
Mike Mallinson has been appointed to lead the Access Partnership in the role of President.
Mike is a highly regarded pharma executive with over 30 years experience gained both agency and client-side, who has presented and published opinion papers on market access issues at many international meetings. Mike is supported by Rob White, Global Director of Market Access and Dr Shrinivas Rao Mukku, Global Director of Pricing and Reimbursement.Commenting on his appointment, Mike said, “I am delighted to be taking on this challenging new position. Our aim is for the Access Partnership to become the preferred commercial partner for delivering market access solutions, by gaining a reputation for delivering the best payer and key stakeholder insights and outstanding strategic consulting services. We recognise the access challenges facing our clients, particularly across the Tier 1 and Tier 2 Emerging Markets - having an Asia Pacific presence will mean we are well placed to meet our clients’ needs in this region.”The Access Partnership will be attending and exhibiting at ISPOR’s (International Society for Pharmacoeconomics and Outcomes Research) Annual European Congress at the ICC in Berlin 5-7 November, where they will be giving two podium and two poster presentations. Delegates are able to visit them on Stand 34 of the exhibition. Sign up to receive Rapport Rapport is our…
Announcing a new strategic market access consultancy
The Research Partnership is today launching a new market access consultancy called "The Access Partnership" which will provide services to the pharmaceutical, biotech and medtech industries.
The Access Partnership will work with manufacturers to help them develop the value strategy for their technologies, including pricing, market access and payer engagement, in order to achieve commercial success for their innovations. The company’s global headquarters are based in London, UK, with other offices in the US and Singapore.The company has also made two senior appointments. Rob White joins as Global Director of Market Access and Dr Shrinivas Rao Mukku joins as Global Director of Pricing and Reimbursement.Rob White (shown above) has over 20 years experience within the pharma industry at Sanofi Aventis and MSD leading on a number of roles including delivering market access strategies and tools to support brands in key areas such as diabetes, HIV, oncology, cardiovascular as well as the device space. Rob has developed an extensive payer network which he has used to help clients deliver relevant payer value propositions and support segmentation across the EU and US markets. Rob has also delivered training for pharma KAM teams and supported teams with contract negotiations and the development of business cases to drive brand market access.Shrinivas Rao Mukku has 18 years of research management, training and consultancy experience in Europe and South East Asia. In…